Karol Nowicki-Osuch is currently a Junior Group Leader at the German Cancer Research Center (DKFZ) in Heidelberg, Germany, and an IICD Affiliate Member. His research focused on the early biology of esophageal and gastric cancers with particular focus on approaches targeting early detection of these diseases.
Previously, Karol was an Associate Research Scientist in IICD. Karol was spearheading IICD's major experimental focus on the development of experimental and computational methods for the analysis of solid tumors in three dimensions in partnership with the New York Genome Center and Cambridge University. Before joining the Institute, Karol was a Postdoctoral Research Associate in Prof Rebecca Fitzgerald's laboratory at the University of Cambridge UK since 2016. Karol’s experience and interests lie at the interface between wet- and dry-lab cancer biology research. Over recent years, his work has been focused on questions associated with the early stages of oesophageal cancer development including the transition from normal to cancer tissues.
